Israeli medtech company BrainQ, a developer of AI-powered technology to treat neuro disorders, announced on Thursday that the US Food and Drug Administration (FDA) has designated its AI-powered therapeutic solution to reduce disability following stroke, as a Breakthrough Device.

Read more here.